Cencora Cash Flow Statement
COR / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Cencora generated $3.9B in operating cash flow and $3.2B in free cash flow in FY2025. Free cash flow margin was 1.0% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.32 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $1.6B | $1.5B | $1.5B | -$3.4B | $855.4M | -$3.4B | $855.4M | $1.7B | $364.5M | $1.4B | -$138.2M | $274.2M | $433.7M | $719.0M | $706.6M |
| Depreciation & Amortization | $1.1B | $1.1B | $505.2M | $391.1M | $462.4M | $391.1M | $462.4M | $465.1M | $397.6M | $364.7M | $248.6M | $188.7M | $162.2M | $134.4M | $101.4M |
| Operating Cash Flow | $3.9B | $3.5B | $2.7B | $2.2B | $2.3B | $2.2B | $2.3B | $1.4B | $1.5B | $3.2B | $3.9B | $1.5B | $788.1M | $1.3B | $1.2B |
| Capital Expenditures | $668.0M | $487.2M | $438.2M | $369.7M | $310.2M | $369.7M | $310.2M | $336.4M | $466.4M | $464.6M | $231.6M | $264.5M | $202.4M | $133.3M | $156.1M |
| Free Cash Flow | $3.2B | $3.0B | $2.2B | $1.8B | $2.0B | $1.8B | $2.0B | $1.1B | $1.0B | $2.7B | $3.7B | $1.2B | $585.7M | $1.2B | $1.0B |
| Share Buybacks | $435.5M | $1.5B | $82.2M | $420.4M | $674.0M | $420.4M | $674.0M | $639.2M | $329.9M | $2.3B | $1.9B | $753.9M | $484.2M | $1.2B | $840.6M |
| Dividends Paid | $437.1M | $416.2M | $366.6M | $343.6M | $339.0M | $343.6M | $339.0M | $333.0M | $320.3M | $288.5M | $253.9M | $214.5M | $195.7M | $132.8M | $117.6M |
| FCF Margin | 1.0% | 1.0% | 1.0% | 1.0% | 1.1% | 1.0% | 1.1% | 0.6% | 0.7% | 1.8% | 2.7% | 1.0% | 0.7% | 1.5% | 1.3% |